Vitreomacular traction

There has been some recent discussion around Ocriplasmin – trade name Jetrea- a recombinant protease with activity against fibronectin and laminin, components of the vitreoretinal interface. It is used for treatment of symptomatic vitreomacular adhesion, via intravitreal injection, for which it has recently been approved for use in Australia.
Sometimes controversial as a single treatment as many cases of VMT will still require surgery , here is such a a case that I wanted to share with you.

60yo man , phakic , noticing progressive deterioration in this eye.

Leave a Comment

You must be logged in to post a comment.